These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16714396)

  • 1. Survivin promoter polymorphism and cervical carcinogenesis.
    Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
    J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
    Chatterjee K; Williamson AL; Hoffman M; Dandara C
    J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.
    Su TH; Chang TY; Lee YJ; Chen CK; Liu HF; Chu CC; Lin M; Wang PT; Huang WC; Chen TC; Yang YC
    Carcinogenesis; 2007 Jun; 28(6):1237-40. PubMed ID: 17341658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
    Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
    J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
    Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
    Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of apoptosis proteins in human cervical cancer.
    Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
    BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.
    Wagner M; Schmelz K; Dörken B; Tamm I
    Leuk Res; 2008 Jul; 32(7):1054-60. PubMed ID: 18206228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
    Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Fas gene promoter polymorphism in cervical cancer patients.
    Dybikowska A; Sliwinski W; Emerich J; Podhajska AJ
    Int J Mol Med; 2004 Sep; 14(3):475-8. PubMed ID: 15289903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
    Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
    Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
    Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
    Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
    Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
    Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.